Many users do not realize they are dehydrated until they develop headaches, constipation, or worsened nausea
As such, we consider all available options and tailor therapy programs that are tailored to each patients needs
Drugs with a glucagon-like peptide-1 (GLP-1) classification such as Novo Nordisk's Wegovy and Ozempic and Eli Lilly's Zepbound and Mounjaro, help in the regulation of digestion, appetite, and sugar which aid in weight loss
[1] [2] Marketed under the brand names Mounjaro (for diabetes) and Zepbound (for weight management as an adjunct to reduced-calorie diet and increased physical activity), tirzepatide represents the first dual incretin receptor agonist available in clinical practice
It is administered as a small subcutaneous weekly injection
Remington R, Bechtel C, Larsen D, Samar A, Doshanjh L, Fishman P, et al